VS
Venkata Siva Reddy Pallempalli
About Venkata Siva Reddy Pallempalli
Data last updated:
Venkata Siva Reddy Pallempalli is a Director at Chemeca Drugs Private Limited (since 2018) and Director at Sciegen Pharmaceuticals India Private Limited (since 2018). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹134 Cr; the largest is Chemeca Drugs Private Limited at ₹128 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Jul 2018 | 2003 | ₹128 Cr (FY 2025) | Active | |
| Director | 10 Aug 2018 | 2013 | ₹6.22 Cr (FY 2024) | Active |
Board colleagues of Venkata Siva Reddy Pallempalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alla Bhaskara Reddy | 06547447 | Chemeca Drugs Private Limited , Sciegen Pharmaceuticals India Private Limited | Director |
| Pailla Malla Reddy | 06876164 | Chemeca Drugs Private Limited , Sciegen Pharmaceuticals India Private Limited | Managing Director |
| Saketh Reddy Pailla | 08379312 | Chemeca Drugs Private Limited , Sciegen Pharmaceuticals India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkata Siva Reddy Pallempalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkata Siva Reddy Pallempalli
Venkata Siva Reddy Pallempalli currently holds 2 directorships: Chemeca Drugs Private Limited (Director, since 27 Jul 2018, revenue ₹128 Cr (FY 2025)); Sciegen Pharmaceuticals India Private Limited (Director, since 10 Aug 2018, revenue ₹6.22 Cr (FY 2024)).
Venkata Siva Reddy Pallempalli was first appointed on 27 Jul 2018 as Director at Chemeca Drugs Private Limited.
The 2 current companies of Venkata Siva Reddy Pallempalli that report revenue have a combined latest revenue of ₹134 Cr: Chemeca Drugs Private Limited ₹128 Cr (FY 2025); Sciegen Pharmaceuticals India Private Limited ₹6.22 Cr (FY 2024).
The current boards of Venkata Siva Reddy Pallempalli's companies include Alla Bhaskara Reddy (Chemeca Drugs Private Limited), Pailla Malla Reddy (Chemeca Drugs Private Limited), Saketh Reddy Pailla (Chemeca Drugs Private Limited).